FDA Adverse Event Injury Summary report: N

FREESTYLE AORTIC ROOT BIOPROSTHESIS

MDR report key: 12306952 · Received August 11, 2021

Report

Report Number
2025587-2021-02518
Event Type
Injury
Date Received
August 11, 2021
Date of Event
October 14, 2019
Report Date
August 11, 2021
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
LWR
PMA / PMN Number
P970031
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: WILDER T., ET AL. RAPID-DEPLOYMENT AORTIC VALVE REPLACEMENT AFTER AORTIC ROOT REPLACEMENT: A SAFE ALTERNATIVE TO REDO ROOT REPLACEMENT. J CARD SURG. 2020 JAN;35(1):222-225. DOI: 10.1111/JOCS.14278. PMID: 31609491. EPUB 2019 OCT 14. EARLIEST DATE OF PUBLISH USED FOR DATE OF EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A CASE SERIES USING RAPID-DEPLOYMENT AORTIC VALVE PROSTHESES TO AVOID SURGICAL VALVE REPLACEMENT. ALL DATA WERE COLLECTED FROM A SINGLE CENTER. THE STUDY POPULATION INCLUDED THREE PATIENTS (TWO FEMALE/ONE MALE, MEAN AGE (B)(6)), TWO OF WHOM HAD PREVIOUSLY UNDERGONE SURGICAL AORTIC ROOT REPLACEMENT USING MEDTRONIC FREESTYLE AORTIC ROOT CONDUITS (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). FOR THE TWO MEDTRONIC FREESTYLE PATIENTS, ADVERSE EVENTS INCLUDED: NEED FOR TRANSCATHETER AORTIC VALVE REPLACEMENT DUE TO CONDUIT DEGENERATION. THE CONDUITS SHOWED MODERATE-SEVERE ANNULAR/VALVE LEAFLET CALCIFICATION, LARGE SUB-ANNULAR FIBROUS PANNI AND HIGH AORTIC TRANSVALVULAR GRADIENTS PER ECHOCARDIOGRAPHY. PATIENTS EXPERIENCED MODERATE-SEVERE AORTIC STENOSIS/INSUFFICIENCY WITH SYMPTOMS OF HEART FAILURE INCLUDING PROGRESSIVE FATIGUE AND SHORTNESS OF BREATH. THE PATIENTS WERE HOSPITALIZED AND UNDERWENT AORTIC VALVE REPLACEMENT. THE CALCIFIED FREESTYLE LEAFLET VALVES WERE EXCISED, ANNULAR DEBRIDEMENT WAS PERFORMED AND THEN THE FREESTYLE CONDUITS WERE SERIALLY DILATED. NON-MEDTRONIC TRANSCATHETER VALVES WERE THEN SEATED WITHIN THE CONDUITS. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS DIRECTLY ASSOCIATED WITH THE ADVERSE EVENTS. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1204357 FREESTYLE AORTIC ROOT BIOPROSTHESIS HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC HEART VALVES DIVISION 995

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| L| R